← Back to Search

Monoclonal Antibodies

Treatment A: Lecanemab 720 mg for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Eisai Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to day 50
Awards & highlights

Summary

This trial is testing if lecanemab works the same way when given through a vial or an auto-injector in healthy participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to day 50
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 50 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Number of Participants With Abnormal Laboratory Values
Number of Participants With Abnormal Vital Signs Values
Number of Participants With Anti-drug Antibodies (ADAs)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment B: Lecanemab 720 mgExperimental Treatment1 Intervention
Participants will receive a single SC dose of lecanemab 720 mg in the lower abdomen using AI on Day 1.
Group II: Treatment A: Lecanemab 720 mgExperimental Treatment1 Intervention
Participants will receive a single SC dose of lecanemab 720 milligram (mg) in the lower abdomen using a vial and syringe on Day 1.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lecanemab
2022
Completed Phase 3
~2130

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Eisai Inc.Lead Sponsor
518 Previous Clinical Trials
159,177 Total Patients Enrolled
~53 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top